National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 76087 [2020-26150]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 229 / Friday, November 27, 2020 / Notices
through the advice and counsel of this
group.
Inquiries may be directed to Claire
Harris, Director, Office of Federal
Advisory Committee Policy, Office of
the Director, National Institutes of
Health, 6701 Democracy Boulevard,
Suite 1000, Bethesda, Maryland 20892
(Mail Stop Code 4875), Telephone (301)
496–2123, or harriscl@mail.nih.gov.
Dated: November 20, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–26167 Filed 11–25–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
jbell on DSKJLSW7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Vaccine Research Center
Board of Scientific Counselors, NIAID.
The meeting will be closed to the public
as indicated below in accordance with
the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended for the review, discussion,
and evaluation of individual grant
applications conducted by the
NATIONAL INSTITUTE OF ALLERGY
AND INFECTIOUS DISEASES,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Vaccine Research
Center Board of Scientific Counselors, NIAID.
Date: December 15–16, 2020.
Time: 8:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 40 Convent Drive, Bethesda, MD
20892, (Virtual Meeting).
Contact Person: John R. Mascola, MD,
Director, Vaccine Research Center, National
Institute of Allergy and Infectious Diseases,
National Institutes of Health, 40 Convent
Drive, Bethesda, MD 20892, (301) 496–1852,
jmascola@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
VerDate Sep<11>2014
19:29 Nov 25, 2020
Jkt 253001
76087
Dated: November 20, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
Dated: November 24, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–26150 Filed 11–25–20; 8:45 am]
[FR Doc. 2020–26369 Filed 11–25–20; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
Government-Owned Inventions;
Availability for Licensing
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Initial Review Group; Behavior and
Social Science of Aging Review Committee
NIA–S.
Date: February 4–5, 2021.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Carmen Moten, Ph.D.,
MPH, Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
National Institutes of Health, Gateway Bldg.,
2C212, 7201 Wisconsin Avenue, Bethesda,
MD 20814, (301) 402–7703, cmoten@
mail.nih.gov.
Name of Committee: National Institute on
Aging Initial Review Group; Biological Aging
Review Committee NIA–B.
Date: February 11–12, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Bita Nakhai, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, National
Institutes of Health, Gateway Bldg., 2C212,
7201 Wisconsin Avenue, Bethesda, MD
20892, (301) 402–7701, nakhaib@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
PO 00000
Frm 00084
Fmt 4703
Sfmt 4703
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing to achieve expeditious
commercialization of results of
federally-funded research and
development.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Licensing information may be obtained
by communicating with Betty B. Tong,
Ph.D., National Institute of Diabetes and
Digestive and Kidney Diseases,
Technology Advancement Office, 12A
South Drive Suite 3011, Bethesda, MD
20892; telephone: 301–451–7836; email:
tongb@mail.nih.gov. A signed
Confidential Disclosure Agreement may
be required to receive any unpublished
information.
SUPPLEMENTARY INFORMATION:
Technology description follows.
Triazole Derivatives as P2Y14 Receptor
Antagonists
The technology describes the
composition of small molecule
compounds that are antagonists of the
P2Y14 receptor. Also provided are
methods of using the compounds,
including a method of treating a
disorder, such as inflammation,
diabetes, insulin resistance,
hyperglycemia, a lipid disorder, obesity,
a condition associated with metabolic
syndrome, and asthma, and a method of
antagonizing P2Y14 receptor activity in
a cell. This technology is available for
licensing for commercial development
in accordance with 35 U.S.C. 209 and 37
CFR part 404.
Potential Commercial Applications:
Development of P2Y14 receptor
antagonist for treatment of disorders,
such as:
• Inflammation
• diabetes
• obesity
• asthma
E:\FR\FM\27NON1.SGM
27NON1
]]>Agencies
[Federal Register Volume 85, Number 229 (Friday, November 27, 2020)]
[Notices]
[Page 76087]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-26150]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Vaccine Research
Center Board of Scientific Counselors, NIAID. The meeting will be
closed to the public as indicated below in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual grant applications conducted by the NATIONAL INSTITUTE OF
ALLERGY AND INFECTIOUS DISEASES, including consideration of personnel
qualifications and performance, and the competence of individual
investigators, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: Vaccine Research Center Board of Scientific
Counselors, NIAID.
Date: December 15-16, 2020.
Time: 8:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 40 Convent Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: John R. Mascola, MD, Director, Vaccine Research
Center, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 40 Convent Drive, Bethesda, MD 20892,
(301) 496-1852, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: November 20, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-26150 Filed 11-25-20; 8:45 am]
BILLING CODE 4140-01-P
